PATHA joins WPATH, EPATH, USPATH, AsiaPATH, CPATH, and AusPATH, to respond to the harmful Bell v. Tavistock Judgment in the UK

18 Dec 2020 10:44 AM | PATHA (Administrator)

WPATH, EPATH, USPATH, AsiaPATH, CPATH, AusPATH, and PATHA Response to Bell v. Tavistock Judgment

[Update 1/1/2021: AusPATH have also released their own statement about this ruling which is available here.]

Statement Regarding Medical Affirming Treatment, Including Puberty Blockers for Transgender Adolescents

The Boards of Directors of the World Professional Association for Transgender Health (WPATH), the European Association for Transgender Health (EPATH), the United States Professional Association for Transgender health (USPATH), the Asia Professional Association for Transgender Health (AsiaPATH), the Canadian Association for Transgender Health (CPATH), the Australian Professional Association for Trans Health (AusPATH), and the Professional Association for Transgender Health Aotearoa (PATHA) all strongly disagree with the recent judgement of the London High Court in Bell v. Tavistock. We believe this decision will result in significant harm to the affected children and their families. We oppose this ruling and urge that this ruling be appealed and overturned.

Click here for the full statement.


               


About PATHA

The Professional Association for Transgender Health Aotearoa (PATHA) is an interdisciplinary professional organisation working to promote the health, wellbeing, and rights of transgender people. We are a group of professionals who have experience working for transgender health in clinical, academic, community, legal and other settings.

Powered by Wild Apricot Membership Software